Bioretec appoints Rami Ojala as Sales and Marketing Director and member of the Management Team
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Bioretec appoints Rami Ojala as Sales and Marketing Director and member of the Management Team

Rami Ojala (46) has been appointed as Bioretec Ltd’s new Sales and Marketing Director and member of the Management Team as of 1 January 2022. He will report to Timo Lehtonen, Chief Executive Officer of Bioretec.

Ojala will succeed Lauri Hokkanen, Bioretec’s current Sales and Marketing Director and member of the Management Team, who has decided to pursue new career opportunities outside the company. Hokkanen will continue in Bioretec’s employ until 31 January 2022, familiarizing his successor to the new role.

Rami Ojala has close to 15 years of experience from medical device sales and marketing. He joins Bioretec from Impulse Dynamics GmbH, where he has worked as Regional and Country Manager, Finland & Baltics since 2017, responsible for sales and marketing activities, launching a new therapy for symptomatic heart failure, distributor management as well as customer training and education. Prior to this, he held various sales and marketing positions for Medtronic’s medical device portfolio and worked as sales representative for Oriola-KD Healthcare.

”We are delighted to have Rami Ojala strengthen Bioretec’s Management Team and lead the company’s sales and marketing operations.  Bioretec's vision is to become a globally recognized medical device company and a leader in bioresorbable metal implants. Rami will play a significant role in executing our growth strategy through driving sales and finding new growth avenues. His comprehensive competence and international experience from medical devices, launching new products and therapies, opening new geographical markets and working with distributors will meet our needs perfectly and support our growth journey. I would also like to warmly thank Lauri Hokkanen for his contribution in Bioretec's sales and marketing activities and wish him all the best for the future," says Timo Lehtonen, Chief Executive Officer of Bioretec.

Bifogade filer

Change in the Bioretec Management Team_3.12.2021https://mb.cision.com/Main/20509/3465746/1505413.pdf

Nyheter om Bioretec

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Bioretec

Senaste nytt